Streetbeat News

Stock Prices

OBIO

Orchestra BioMed Holdings (NASDAQ: OBIO) is set to join the Russell 3000, Russell 2000, and Russell Microcap indexes after the 2023 annual reconstitution, effective June 26, 2023.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 12:12 pm

TWST

Twist Bioscience has published preclinical data validating its GLP-1R antagonist antibody, TB-222-023, as a potential treatment for congenital hyperinsulinism. The antibody was discovered and optimized using Twist's synthetic DNA libraries and antibody engineering services.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 12:11 pm

OVID

Ovid Therapeutics has been added to the Russell 3000 Index, which could potentially increase its visibility and attract more investors.

Portfolio Pulse from Bill Haddad

June 26, 2023 | 12:11 pm

DHC

Diversified Healthcare Trust (DHC) reported a 36% decline in SHOP NOI for May 2023 compared to April 2023, indicating an inconsistent recovery. DHC also provided insight into its debt incurrence covenant and reiterated its board's recommendation for the pending merger with Office Properties Income Trust.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 12:10 pm

MRCY

Mercury Systems' shares are trading lower after the company announced its decision to pursue a standalone strategy and search for a new CEO, following a review of strategic alternatives.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 12:09 pm

PSTX

Poseida Therapeutics (NASDAQ:PSTX) is set to join the Russell 3000 and Russell 2000 Indexes after the 2023 annual reconstitution. The inclusion is expected to increase visibility among the global investment community and help build awareness among investors.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 12:07 pm

ENVB

Enveric Biosciences has developed a Phase 1-ready formulation for EB-373, a psilocin prodrug for anxiety disorder treatment, and initiated scaled-up manufacturing. The new formulation is expected to enhance scalability, stability, and delivery for ongoing preclinical studies and planned clinical development.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 12:07 pm

SLNH

Soluna Holdings (NASDAQ: SLNH), the parent company of Soluna Computing, has been granted a 180-day extension by Nasdaq to regain compliance with the minimum per share bid price requirement. The company now has until December 18, 2023, to meet the $1 minimum per share bid requirement.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 12:07 pm

CXM

Sprinklr (NYSE:CXM) is set to join the Russell 2000 and Russell 3000 Indexes after the 2023 annual reconstitution, effective June 26, 2023. The inclusion is expected to enhance the company's exposure within the investment community and is considered a significant milestone for Sprinklr.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 12:06 pm

FUSN

Fusion Pharmaceuticals (NASDAQ:FUSN) announced interim data from the Phase 1 trial of FPI-1434 in patients with solid tumors expressing IGF-1R. The data showed that pre-administration of cold antibody prior to administering radiolabeled FPI-1434 has the potential to enhance the therapeutic index and improve the safety profile compared to hot-only dosing.

Portfolio Pulse from Happy Mohamed

June 26, 2023 | 12:05 pm